• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过停流荧光能量转移法测量描述弹性蛋白酶-α1-蛋白酶抑制剂复合物可逆形成和不可逆重排的速率常数。

Stopped flow fluorescence energy transfer measurement of the rate constants describing the reversible formation and the irreversible rearrangement of the elastase-alpha1-proteinase inhibitor complex.

作者信息

Mellet P, Boudier C, Mely Y, Bieth J G

机构信息

Laboratoire d'Enzymologie, INSERM U 392, CNRS URA 491, Université Louis Pasteur de Strasbourg, Strasbourg F-67000, France.

出版信息

J Biol Chem. 1998 Apr 10;273(15):9119-23. doi: 10.1074/jbc.273.15.9119.

DOI:10.1074/jbc.273.15.9119
PMID:9535901
Abstract

Serpins are thought to inhibit proteinases by first forming a Michaelis-type complex that later converts into a stable inhibitory species. However, there is only circumstantial evidence for such a two-step reaction pathway. Here we directly observe the sequential appearance of two complexes by measuring the time-dependent change in fluorescence resonance energy transfer between fluorescein-elastase and rhodamine-alpha1-protease inhibitor. A moderately tight initial Michaelis-type complex EI1 (Ki = 0.38-0.52 microM) forms and dissociates rapidly (k1 = 1.5 x 10(6) M-1 s-1, k-1 = 0.58 s-1). EI1 then slowly converts into EI2 (k2 = 0.13 s-1), the fluorescence intensity of which is stable for at least 50 s. The two species differ by their donor-acceptor energy transfer efficiency (0. 41 and 0.26, respectively). EI2 might be the final product of the elastase + inhibitor association because its transfer efficiency is the same as that of a complex incubated for 30 min. The time-dependent change in fluorescence resonance energy transfer between fluorescein-elastase and rhodamine-eglin c, a canonical inhibitor, again allows the fast formation of a complex to be observed. However, this complex does not undergo any fluorescently detectable transformation.

摘要

丝氨酸蛋白酶抑制剂(Serpins)被认为首先通过形成米氏型复合物来抑制蛋白酶,该复合物随后会转化为稳定的抑制性物质。然而,对于这种两步反应途径仅有间接证据。在此,我们通过测量荧光素 - 弹性蛋白酶与罗丹明 - α1 - 蛋白酶抑制剂之间荧光共振能量转移的时间依赖性变化,直接观察到了两种复合物的相继出现。一种中等紧密的初始米氏型复合物EI1(Ki = 0.38 - 0.52微摩尔)形成并迅速解离(k1 = 1.5×10⁶ M⁻¹ s⁻¹,k⁻¹ = 0.58 s⁻¹)。然后EI1缓慢转化为EI2(k2 = 0.13 s⁻¹),其荧光强度至少在50秒内保持稳定。这两种物质的供体 - 受体能量转移效率不同(分别为0.41和0.26)。EI2可能是弹性蛋白酶 + 抑制剂结合的最终产物,因为其转移效率与孵育30分钟的复合物相同。荧光素 - 弹性蛋白酶与典型抑制剂罗丹明 - 埃格林c之间荧光共振能量转移的时间依赖性变化,再次使我们能够观察到复合物的快速形成。然而,这种复合物并未发生任何可通过荧光检测到的转化。

相似文献

1
Stopped flow fluorescence energy transfer measurement of the rate constants describing the reversible formation and the irreversible rearrangement of the elastase-alpha1-proteinase inhibitor complex.通过停流荧光能量转移法测量描述弹性蛋白酶-α1-蛋白酶抑制剂复合物可逆形成和不可逆重排的速率常数。
J Biol Chem. 1998 Apr 10;273(15):9119-23. doi: 10.1074/jbc.273.15.9119.
2
Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin.重组依格林C对人胰腺弹性蛋白酶的抑制动力学。弹性蛋白的影响。
Biochem J. 1990 Sep 15;270(3):639-44. doi: 10.1042/bj2700639.
3
Evidence that translocation of the proteinase precedes its acylation in the serpin inhibition pathway.
J Biol Chem. 2000 Apr 14;275(15):10788-95. doi: 10.1074/jbc.275.15.10788.
4
Kinetics of the interaction of chymotrypsin with eglin c.胰凝乳蛋白酶与抑肽酶C相互作用的动力学
Biochem J. 1991 Nov 15;280 ( Pt 1)(Pt 1):27-32. doi: 10.1042/bj2800027.
5
Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor.多核苷酸对黏液蛋白酶抑制剂和α1-蛋白酶抑制剂抑制中性粒细胞弹性蛋白酶的影响。
Biochemistry. 1998 Nov 17;37(46):16416-22. doi: 10.1021/bi981536o.
6
Kinetic dissection of alpha 1-antitrypsin inhibition mechanism.
J Biol Chem. 2002 Apr 5;277(14):11629-35. doi: 10.1074/jbc.M111168200. Epub 2002 Jan 10.
7
The P6-P2 region of serpins is critical for proteinase inhibition and complex stability.丝氨酸蛋白酶抑制剂(serpins)的P6-P2区域对于蛋白酶抑制作用和复合物稳定性至关重要。
Biochemistry. 1997 Aug 5;36(31):9562-70. doi: 10.1021/bi970651g.
8
Kinetic mechanism of protease inhibition by alpha1-antitrypsin.α1-抗胰蛋白酶抑制蛋白酶的动力学机制。
Biochem Biophys Res Commun. 2004 Oct 15;323(2):409-15. doi: 10.1016/j.bbrc.2004.08.105.
9
Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa.弹性蛋白酶抑制剂对金黄色葡萄球菌和铜绿假单胞菌蛋白酶失活的不同敏感性。
Biol Chem Hoppe Seyler. 1991 Nov;372(11):963-70. doi: 10.1515/bchm3.1991.372.2.963.
10
Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G.依格林C与人类白细胞弹性蛋白酶及组织蛋白酶G相互作用的动力学研究。
Biol Chem Hoppe Seyler. 1987 Apr;368(4):299-308. doi: 10.1515/bchm3.1987.368.1.299.

引用本文的文献

1
Mechanical forces regulate elastase activity and binding site availability in lung elastin.机械力调节肺弹性蛋白中弹性蛋白酶的活性和结合位点的可及性。
Biophys J. 2010 Nov 3;99(9):3076-83. doi: 10.1016/j.bpj.2010.09.018.
2
Functional unfolding of alpha1-antitrypsin probed by hydrogen-deuterium exchange coupled with mass spectrometry.通过氢氘交换结合质谱法探究α1-抗胰蛋白酶的功能去折叠
Mol Cell Proteomics. 2009 May;8(5):1072-81. doi: 10.1074/mcp.M800365-MCP200. Epub 2009 Jan 11.
3
Serpins in plants and green algae.植物和绿藻中的丝氨酸蛋白酶抑制剂
Funct Integr Genomics. 2008 Feb;8(1):1-27. doi: 10.1007/s10142-007-0059-2. Epub 2007 Nov 6.
4
A segment of gamma ENaC mediates elastase activation of Na+ transport.γ-ENaC的一个片段介导Na⁺转运的弹性蛋白酶激活。
J Gen Physiol. 2007 Dec;130(6):611-29. doi: 10.1085/jgp.200709781. Epub 2007 Nov 12.
5
Conformational change in elastase following complexation with alpha1-proteinase inhibitor: a CD investigation.弹性蛋白酶与α1-蛋白酶抑制剂复合后的构象变化:圆二色光谱研究
Biochem J. 2003 Feb 15;370(Pt 1):345-9. doi: 10.1042/BJ20020890.
6
Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease.丝氨酸蛋白酶抑制剂α1-抗糜蛋白酶的无活性构象表明反应性环的两阶段插入:对抑制功能和构象疾病的影响
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):67-72. doi: 10.1073/pnas.97.1.67.